British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...

UK-based big pharma GlaxoSmithKline (GSK) has released its Q2 2025 results, which highlight the varying successes of its ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

GSK expects to deliver annual sales and profit growth towards the top end of its forecasts after beating second-quarter ...

British drugmaker GSK said on Wednesday it is in talks with the Trump administration about ways to lower U.S. drug costs, ...

GSK Plc reported better-than-expected profit and raised its estimates for revenue at two key divisions in a report that ...

GSK ( NYSE: GSK) CEO Emma Walmsley said on Wednesday that her company is in discussions with the Trump administration on how ...

As for the clinical presentation, most kids had fever (93%) and seizures (68%). They also had elevated liver enzymes (78%), ...

GSK, led by boss Emma Walmsley (pictured), saw revenues rise 5% to £15.5bn in the first half of the year and profits were up 41% to £4.2bn.

Investing.com -- GSK (LON: GSK) on Wednesday raised its full-year earnings guidance after posting a 35% rise in ...

GSK lifted profit guidance for the year on Wednesday after sales of the drugmaker's 'specialty' medicines soared.

CEO Emma Walmsley maintained that continued investment in the U.S. is a priority for the pharma to ensure its medicines for ...